Hi {{ first name | there}},

Most mood advice fails for one boring reason: the measurement is too blunt.

We treat mood like a "before/after" photo:

  • one big questionnaire at baseline

  • one big questionnaire at the end

  • and then we declare "it worked" or "it didn't"

But mood usually doesn't jump. It drifts.

This week is about learning to detect drift – and then using it as a decision tool. Same theme, three angles:

  • Probiotics: the signal shows up in daily data, not in big pre/post questionnaires.

  • Collagen: connective tissue improves slowly, but the mechanical outcomes are measurable.

  • Peptides: hype travels faster than evidence, and "unapproved" is a real category – not a vibe.

-LONGEVITY PLAYBOOK-

If this helps, consider forwarding it to one person who says "I'm fine" – but is secretly running on edge.

The "Mood Microdose" Experiment

Why Probiotics Might Work (And Why You Don't Notice)

We've been told again and again: take the capsule → feel calmer.

Then reality hits: Most people feel ... nothing. And the internet concludes: "probiotics are placebo."

A more honest explanation is simpler: the effect is small, and our measurement is noisy.

The New Evidence: Daily Mood Beats "Before/After"

A 2025 randomized, double-blind, placebo-controlled trial tested a multispecies probiotic in 88 healthy volunteers – and measured mood three ways:

  • standard questionnaires

  • emotional processing tasks

  • daily mood reports

The Result:

  • Questionnaires: few clear changes

  • Daily reports: a clear signal – negative mood improved, starting after about 2 weeks

Translation: the intervention didn't suddenly "start working" on day 14.
The measurement finally became sensitive enough to detect a drift.

The Context: It's Not Just One Study

This is where probiotics get interesting – and messy.

In unmedicated depression: a modest positive signal

A 2025 systematic review/meta-analysis looked at probiotic monotherapy in unmedicated depression (6 RCTs, n = 341) and found a small but statistically significant reduction in depressive symptoms.

Translation: promising – but not "antidepressant in a capsule".

The Mechanism (Plausible, Still Not Fully Settled)

The gut-brain axis isn't magic. It's plumbing + signaling:

  • microbial metabolites

  • immune signaling / inflammation

  • vagal pathways

  • neurotransmitter precursors

But you don't need to fully solve the mechanism to run a clean experiment.

You need:

  1. one variable you can control

  2. one metric you can measure daily

  3. a decision rule so you don't supplement forever

What To Do This Week

Stop arguing about probiotics in theory. Run an experiment in reality.

1. The Metric (The Sensor)

For 14 days, track ONE thing daily, in 10 seconds:

  • Negative mood (0–10)

Optional (but useful):

  • one keyword ("irritable", "flat", "anxious", "tired", "calm")

Do it at the same time each evening. Consistency beats perfection.

2. The Intervention (The Input)

Pick one consistent, boring input:

  • a multispecies probiotic, daily

Keep the other big mood levers stable-ish:

  • sleep window

  • caffeine timing

  • training schedule

3. The Rule (The Decision)

At day 14:

  • If negative mood shows a consistent small downward drift: continue to day 28 and re-check.

  • If nothing changes: stop. That's a win too – you saved money and removed noise.

Bottom Line

Most mood interventions fail in the same way: we ask a noisy brain a vague question once a month.

If you want to detect small wins, you need small, frequent measurements.

THE SUPPLEMENT

Collagen Peptides

The Spring System: Tendon First

Collagen is usually marketed as a "skin" story. But the more interesting angle is mechanical.

Tendons and muscle-tendon units are your "spring system".
If you're chasing running economy, jumping, quick force, and injury resilience, spring matters.

The New Science: Stiffness + Explosive Strength

A 2025 double-blind RCT tested:

  • 10 g/day collagen peptides vs placebo

  • 16 weeks

  • healthy young sedentary men

The findings:

  • Increased muscle stiffness (medial gastrocnemius)

  • Increased Achilles tendon stiffness

  • Improved explosive strength (rate of torque development)

  • No meaningful changes in muscle size or maximal strength

The Context: Collagen Works Best as "Material + Signal"

This isn't a "sprinkle collagen and become a kangaroo" story.
It's a "give building blocks, then apply the right load" story.

1. The classic collagen synthesis experiment (gelatin + vitamin C + jumping)

A crossover trial found that vitamin C-enriched gelatin increased collagen-related amino acids in blood, and serum from participants increased collagen content in engineered human ligaments. It was paired with brief rope skipping.

2. Meta-analysis: a real signal, with mixed certainty

A 2024 systematic review/meta-analysis (19 studies, 768 participants) found statistically significant effects favoring collagen peptides for fat-free mass, tendon morphology, muscle architecture, maximal strength, and recovery – but noted low to moderate certainty (very low certainty for tendon morphology/mechanical properties).

3. Real-world tendon remodeling in athletes

A 10-week study in high-level female soccer players tested training with or without collagen hydrolysate + vitamin C and examined patellar tendon properties.

The Protocol:

If you want to actually test this:

  • Collagen peptides: 10 g daily

  • Timeline: think 8–16 weeks, not 8 days

  • Pair with load: tendons adapt slowly, and they punish ego

Micro-protocol (2–3x/week, 8–12 minutes):

  • Slow calf raises: 3 x 8–12 (controlled eccentric)
    or

  • Submax pogo hops: 3 x 20–40 seconds

If it hurts, back off. Repeatability beats intensity.

-IN THE PRESS-
What we're reading

AI can flag risks for more than 100 health conditions using a single night's sleep, study shows

Health Rounds: Experimental treatment may improve odds of in vitro fertilization success

"Bombshell" doubt cast on discovery of microplastics throughout the human body

Should younger and older people receive different treatments for the same infection?

Exercise to treat depression yields similar results to therapy and antidepressants

-PEPTIDE OF THE WEEK-

BPC-157

The repair peptide with a real preclinical signal – and a human evidence gap

BPC-157 keeps showing up for one reason: the animal data is unusually consistent across different injury models.

Recent reviews in sports medicine and regenerative medicine summarize effects in tendon, ligament, muscle, and bone injury models – often showing faster structural repair and improved function in rodents.

So yes: there is a reason serious people keep discussing it. Even mainstream science communicators have covered BPC-157 in the context of "promise + caution", mainly because the preclinical signal is strong while the human data is thin.

What the recent literature actually says

1. Musculoskeletal repair: promising in preclinical models

A 2025 sports medicine review (covering decades of work) highlights repeated findings that BPC-157 may support healing by influencing growth-factor signaling, inflammation, and tissue remodeling in animal studies.

A separate 2025 narrative review frames it similarly: lots of tendon/tendon-to-bone and muscle repair signals in preclinical work – with the key caveat that translation to humans is not yet proven.

2. Humans: early signals, still small

The 2025 systematic review in orthopaedic sports medicine concludes the preclinical healing signal is consistent across injury models, but highlights the same bottleneck: high-quality human trials are still missing.

On the human side, there is at least one pilot safety datapoint: intravenous BPC-157 up to 20 mg in two healthy adults was reported as well-tolerated (useful, but obviously not definitive).

3. Clinical trials: registered, but results are sparse

A Phase I study (NCT02637284) was registered to assess safety and pharmacokinetics, but publicly available results remain limited, which is why the human evidence base still feels "early" despite all the attention.

A 2025 MDPI review also notes that a Phase I effort started, but the submission of results was ultimately cancelled/never delivered publicly, which is part of why the evidence base still feels "stuck".

The reality check

Here is the most honest framing:

  • Why people are excited: the peptide shows repeated tissue-repair signals in animals, especially for tendons/soft tissue, which are notoriously slow to heal.

  • Why clinicians are cautious: we still lack large, clean human RCTs and high-quality safety data for the typical ways people use it.

  • Why it stays in the conversation: the molecule has a real preclinical repair signal – the open question is whether that signal survives the jump to clean, scalable human data.

And there are two non-negotiable practical constraints:

Regulatory / sourcing reality
  • The FDA lists BPC-157 as a Category 2 bulk drug substance for compounding (citing issues like immunogenicity risk, peptide impurities/characterization complexity, and limited safety info for proposed routes).

  • In sport, it is prohibited under WADA's "unapproved substances" category (S0).

Translation: even if the molecule ends up being useful, the current market reality (purity, labeling, contamination risk) is part of the risk.

HEALTH HACK stance

BPC-157 is best described as: high interest, early evidence, unresolved safety.

If you're subject to anti-doping rules: it's a hard no (risk is not worth it).
If you're not: the smartest posture is "watch the evidence, don't gamble with sourcing". The real upgrade is not joining the hype cycle – it's staying on the right side of evidence and risk.

The practical takeaway: Tendons heal slowly. The best validated levers are still progressive loading, patience, and consistency – with peptides as possible adjuncts, not the foundation.

⚠️ Disclaimer: BPC-157 is not an FDA-approved drug for any indication. Any use for injury repair, pain, gut issues, or "performance/longevity" is experimental and should be treated as a monitored medical decision, not a DIY protocol. Human safety data is limited, and effects, dosing, and long-term risks are not well established.

Avoid if pregnant/breastfeeding, with active (or suspected) malignancy, autoimmune or immunocompromising conditions, severe liver/kidney disease, or if you are on anticoagulants/antiplatelet therapy or other complex medications – unless your clinician explicitly approves. Athletes: BPC-157 is considered an unapproved substance and is prohibited under anti-doping rules.

Do not self-source peptides. Purity, contamination, dosing, and storage are the primary risks. Educational content only – not medical advice.

Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this newsletter.

QUICK POLL

LAST WEEK'S POLL RESULTS

What's your biggest bottleneck right now for getting stronger?

26.8% 😴 Recovery (sleep/stress derails me)
24.4% 🍗 Protein logistics (I miss 30–40g per meal)
19.5% 🏋️ Consistency (I don't train 2–3x/week)
17.1% 🤷 Not sure – I want a simple plan
12.2% 🔥 Effort (I show up, but I don't train close to fatigue)

Reader note: "I think consistency and effort can be of the most help along with diet and good sleep habits"

QUOTE TO REMEMBER

💡 If the measurement is too blunt, you'll miss the signal.

Closing Note

If you take nothing else from this week, take this: small wins are real, but they are rarely loud.

Most interventions do not come with a "start working" moment. They show up as drift:
a slightly calmer afternoon, one less spike of irritability, a smoother evening.

So run the experiment like a grown-up: one input, one metric, one rule.
If the line moves, you keep it. If it doesn't, you drop it. No guilt. No sunk-cost supplements.

Until next time,
Live longer. Upgrade wisely.
Rolf & the HEALTH HACK team

PS: If someone sent you this, you can subscribe here: https://newsletter.health-hack.com

Keep Reading